+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Retinal Vein Occlusion"

Ophthalmic Photocoagulator - Global Strategic Business Report - Product Thumbnail Image

Ophthalmic Photocoagulator - Global Strategic Business Report

  • Report
  • February 2026
  • 384 Pages
  • Global
From
From
Vitreous Tamponades - Global Strategic Business Report - Product Thumbnail Image

Vitreous Tamponades - Global Strategic Business Report

  • Report
  • February 2026
  • 194 Pages
  • Global
From
Ophthalmic Devices Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Ophthalmic Devices Market - Forecasts from 2025 to 2030

  • Report
  • November 2025
  • 148 Pages
  • Global
From
Diabetic Macular Edema Market Report and Forecast 2025-2034 - Product Thumbnail Image

Diabetic Macular Edema Market Report and Forecast 2025-2034

  • Report
  • July 2025
  • 350 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Retinal Vein Occlusion (RVO) is a condition in which the veins in the retina become blocked, leading to vision loss. It is the second most common cause of vision loss in the elderly, and is often caused by hypertension, diabetes, and other vascular diseases. Treatment for RVO includes laser photocoagulation, intravitreal injections, and vitrectomy. Optical treatments such as optical coherence tomography (OCT) and fundus photography are used to diagnose and monitor the condition. In the RVO market, companies such as Carl Zeiss Meditec, Topcon Corporation, Heidelberg Engineering, Optovue, and Nidek Co. Ltd. are involved in the development and manufacture of optical imaging systems and treatments for RVO. These companies provide a range of products and services, including OCT systems, fundus cameras, laser photocoagulation systems, and intravitreal injections. Show Less Read more